Notch signaling pathway: architecture, disease, and therapeuticsBinghan Zhou, Qian Chu|Signal Transduction and Targeted Therapy|2022Cited by 1k
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumorsMing Yi, Kongming Wu, Mengke Niu et al.|Journal of Hematology & Oncology|2022Cited by 178
DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cellsQian Chu, Kongming Wu|Journal of Hematology & Oncology|2014Cited by 71
The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastomaHarpreet Kaur, Eric H. Raabe, Sabeen Z. Ali et al.|Cancer Letters|2016Cited by 60
Estrogen receptor β1 activation accelerates resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancerShengling Fu, Qian Chu|Oncology Reports|2018Cited by 14